INFLECTRA: payments to doctors
Payments that named INFLECTRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 7,903
- Transactions
- 35,055
- Average per transaction
- $30
The per-transaction average — $30 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,903 providers the average total is $134, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $1,024,106 | 97.0% |
| Whitehall International Inc | $17,913 | 1.7% |
| Celltrion Healthcare Co., Ltd | $8,000 | 0.8% |
| PBG Puerto RICO LLC | $4,494 | 0.4% |
| Pfizer Pharmaceuticals LLC | $769 | 0.1% |
| Hospira, Inc. | $179 | 0.0% |